￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Oncology

The third "broad-spectrum anti-cancer drug" entrectinib is launched!

2025-10-19 11:44:20

Check Details
What are the dosage and precautions of entrectinib? Does entrectinib have any side effects?

2025-10-19 11:44:20

Check Details
Is erlotinib available in the country? How much does a box of erlotinib cost after medical insurance

2025-10-19 11:44:20

Check Details
How many times a day should I take gefitinib (Iressa)? What is the therapeutic effect of gefitinib

2025-10-19 11:44:20

Check Details
Sotoracib (AMG510) is now on the market~

2025-10-19 11:44:20

Check Details
Amg510 (sotorasiib) for the treatment of KRAS-G12C mutated non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Sotoracib (AMG510) is launched! Patient: High cost performance

2025-10-19 11:44:20

Check Details
Tepotinib, the world's first targeted drug for METex14 mutated lung cancer, was approved in Europe

2025-10-19 11:44:20

Check Details
The FDA announced that Rybrevant, the first targeted drug for lung cancer EGFR20ins, has been approved for marketing!

2025-10-19 11:44:20

Check Details
Where can I buy Rybrevant, a targeted therapy for lung cancer (NSCLC)? Are the side effects serious?

2025-10-19 11:44:20

Check Details
40 cigarettes a day can cause cerebral infarction! Smoking may cause these 3 serious diseases to come to you

2025-10-19 11:44:20

Check Details
Lumakras is approved in the United States to treat KRAS-G12C mutated non-small cell lung cancer (NSCLC)!

2025-10-19 11:44:20

Check Details
Category
相关知识